Related Experiment Video

Updated: May 15, 2026

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
12:27

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors

Published on: June 8, 2022

Sphingosine kinase 1 in cancer

Linda A Heffernan-Stroud1, Lina M Obeid

  • 1Molecular and Cellular Biology and Pathobiology Program, Medical University of South Carolina, Charleston, SC, USA.

Advances in Cancer Research
|January 8, 2013
PubMed

Insights

Sphingosine kinase 1 (SK1) promotes cancer growth and metastasis by regulating sphingolipid metabolism. Inhibiting SK1 is a promising strategy for cancer treatment and prevention.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Sphingolipids are bioactive signaling molecules crucial for cell fate.
  • Ceramide and sphingosine act as anti-growth signals, while sphingosine-1-phosphate (S1P) promotes cell growth.
  • Sphingosine kinases (SK1 and SK2) regulate the balance between these opposing signals.

Purpose of the Study:

  • To review the literature on the role of sphingosine kinase 1 (SK1) in cancer.
  • To highlight SK1's function as an oncogene in promoting cancer progression.
  • To emphasize the therapeutic potential of SK1 inhibitors in cancer treatment.

Main Methods:

  • Literature review of studies on sphingolipid metabolism and cancer.
  • Analysis of the role of SK1 in cell viability, tumor growth, and metastasis.
  • Examination of the therapeutic implications of targeting SK1.

Main Results:

  • SK1 plays a significant role in carcinogenesis by regulating sphingolipid levels.
  • SK1 enhances cancer cell viability, tumor growth, and metastasis.
  • Evidence suggests SK1 acts as an oncogene.

Conclusions:

  • Targeting SK1 is a critical strategy for cancer therapy and prevention.
  • Developing specific SK1 inhibitors can complement existing cancer treatments.
  • Further research into SK2's role may reveal additional therapeutic targets.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...